Gupta Aditya K, Pillai Radhakrishnan
J Drugs Dermatol. 2015 Aug;14(8):859-63.
Transungual nail penetrance has traditionally been considered to be the only route of delivery for topical antifungals in onychomycosis. Subungual penetrance may be an alternate route of delivery.
To evaluate the ability of efinaconazole vehicle solution to reach the site of toenail onychomycosis through application to the hyponychium or hyponychium and dorsal nail surface, and assess the impact of the air gap between the nail plate and nail bed.
Twenty-three participants with moderate to severe, mycologically-confirmed onychomycosis were enrolled (mean age, 48.5 years). Two separate applications of vehicle solution containing fluorescein for visualization were applied at the hyponychium or hyponychium and dorsal nail surface. Affected nails were later clipped to allow examination of the nail bed and further examination of the ventral surface of the nail. Spread of formulation was assessed under visible and UV light conditions by photographing target toenails after vehicle application and after nail clipping.
There was a positive correlation between the size of the air gap and degree of affected nail involvement (R2=0.064). Assessments under both visible and UV light indicated that the vehicle had spread to the site of infection, with deposition of fluorescein wherever vehicle had reached, irrespective of application methodology or size of air gap. Nail clippings also indicated absorption into the ventral surface of the nail plate.
The relative contributions of subungual versus transungual application of drug to the nail plate to the efficacy of efinaconazole topical solution, 10% in treating onychomycosis were not assessed.
This study suggests that the low surface tension vehicle developed for efinaconazole topical solution, 10% can reach the site of infection by application to the hyponychium, dorsal or ventral nail surface and nail folds. This multidirectional approach to drug delivery at the site of fungal infection may contribute to the magnitude of efficacy seen in clinical trials.
传统上认为经甲穿透是外用抗真菌药物治疗甲真菌病的唯一给药途径。甲下穿透可能是另一种给药途径。
评估艾氟康唑赋形剂溶液通过应用于甲下皮或甲下皮及指甲背表面到达趾甲甲真菌病感染部位的能力,并评估甲板与甲床之间气隙的影响。
招募了23名中度至重度、经真菌学确诊的甲真菌病患者(平均年龄48.5岁)。在甲下皮或甲下皮及指甲背表面分别应用含荧光素的赋形剂溶液以进行可视化。随后修剪患甲以检查甲床并进一步检查指甲腹面。在应用赋形剂溶液后及剪甲后,通过拍摄目标趾甲,在可见光和紫外光条件下评估制剂的扩散情况。
气隙大小与患甲受累程度之间存在正相关(R2 = 0.064)。可见光和紫外光下的评估均表明赋形剂已扩散至感染部位,荧光素在赋形剂到达的任何部位均有沉积,与应用方法或气隙大小无关。剪甲后的样本也表明药物被吸收至甲板腹面。
未评估药物经甲下与经甲应用于甲板对10%艾氟康唑外用溶液治疗甲真菌病疗效的相对贡献。
本研究表明,为10%艾氟康唑外用溶液开发的低表面张力赋形剂可通过应用于甲下皮、指甲背或腹表面及甲襞到达感染部位。这种在真菌感染部位的多向给药方法可能有助于解释临床试验中所见的疗效程度。